Mirae Asset Global Etfs Holdings Ltd. Tarsus Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 20,202 shares of TARS stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,202
Previous 14,643
37.96%
Holding current value
$1.11 Million
Previous $397,000
67.25%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TARS
# of Institutions
170Shares Held
43.3MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$188 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$180 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$135 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$124 Million6.32% of portfolio
-
Morgan Stanley New York, NY2.21MShares$122 Million0.01% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.47B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...